| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.02 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |